An overview of service quality of continuous positive airway pressure services in Australian pharmacies

Respirology

Volumn 19, Issue 1, 2014, Pages 85-91

  Hanes, Carissa A ^a,c,d   Wong, Keith K H ^b,c,d,e   Saini, Bandana ^a,c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

^c Centre for Integrated Research and Understanding of Sleep   (Australia)

^d WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

continuous positive airway pressure; obstructive sleep apnoea; pharmacy; primary health care; quality of health care

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; DEMOGRAPHY; FACE VALIDITY; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SERVICE; HEALTH SURVEY; HUMAN; NORMAL HUMAN; PHARMACY; POSITIVE END EXPIRATORY PRESSURE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SCORING SYSTEM; SLEEP DISORDERED BREATHING; STAFF TRAINING;

CONTINUOUS POSITIVE AIRWAY PRESSURE; OBSTRUCTIVE SLEEP APNOEA; PHARMACY; PRIMARY HEALTH CARE; QUALITY OF HEALTH CARE;

ADULT; AUSTRALIA; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; PATIENT COMPLIANCE; PHARMACIES; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE;

EID: 84896511526     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12160     Document Type: Article

References (26)

1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. 1993; 328: 1230-1235.
2. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.
3. Kushida CA, Littner MR, Hirshkowitz M, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 2006; 29: 375-380.
4. Marshall N, Wong K, Liu P, et al. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton health study. Sleep 2008; 31: 1079-1085.
5. Giles TL, Lasserson TJ, Smith B, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst. Rev. 2006; 3: CD001106.
6. George CF,. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 2001; 56: 508-512.
7. Weaver TE, Grunstein RR,. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc. Am. Thorac. Soc. 2008; 5: 173-178.
8. Popescu G, Latham M, Allgar V, et al. Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use. Thorax 2001; 56: 727-733.
9. Lewis KE, Seale L, Bartle IE, et al. Early predictors of CPAP use for the treatment of obstructive sleep apnea. Sleep 2004; 27: 134-138.
10. Flemons WW, Douglas NJ, Kuna ST, et al. Access to diagnosis and treatment of patients with suspected sleep apnea. Am. J. Respir. Crit. Care Med. 2004; 169: 668-672.
11. Australasian Sleep Association. 2009. Position paper: best practice guidelines for provision of CPAP therapy. Version 2.2. 14 January 2009. [Accessed 14 Feb 2012.] http://www.sleep.org.au/documents/item/66
12. Australasian Sleep Association. 2012. Standard for sleep disorders services. June 2012. [Accessed 6/10/12.] Available from URL: http://www.sleep.org.au/documents/item/393
13. Shoukry G, Wong K, Bartlett D, et al. Treatment experience of people with obstructive sleep apnoea seeking continuous positive airways pressure device provision through community pharmacies-a role for pharmacists? Int. J. Pharm. Pract. 2011; 19: 318-327.
14. Black J, Saini B, Wong K,. The role of pharmacists in improving the management of sleep disorders in the Australian community. Respirology 2007; 12: A24.
15. Pharmaceutical Society of Australia. 2010. Professional practice standards. Version 4, June 2010. [Accessed 14 Feb 2012.] Available from URL: http://www.psa.org.au/download/standards/professional-practice-standards-v4.pdf
16. The Pharmacy Guild of Australia. Quality care pharmacy program requirements manual. 2011.
17. Donabedian A,. Evaluating the quality of medical care. Milbank Mem. Fund Q. 1966; 44: 166-206.
18. The Pharmacy Guild of Australia. 2008 GUILD DIGEST A survey of independent pharmacy operations in Australia (financial year 2006-07). 2008.
19. Australasian Sleep Association. ASA News. December 2012. [Accessed 17 Dec 2012.] Available from URL: http://www.sleep.org.au/documents/item/418
20. Tze-Min Ang K, Saini B, Wong K,. Sleep health awareness in pharmacy undergraduates and practising community pharmacists. J. Clin. Pharm. Ther. 2008; 33: 641-652.
21. Chai-Coetzer CL, Antic NA, Rowland LS, et al. A simplified model of screening questionnaire and home monitoring for obstructive sleep apnoea in primary care. Thorax 2011; 66: 213-219.
22. Saini B, Krass I, Armour C,. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann. Pharmacother. 2004; 38: 1954-1960.
23. Krass I, Armour C, Mitchell B, et al. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabetes Med. 2007; 24: 677-683.
24. Benrimoj SI, Frommer MS,. Community pharmacy in Australia. Aust. Health Rev. 2004; 28: 238-246.
25. Antic NA, Buchan C, Esterman A, et al. A randomized controlled trial of nurse-led care for symptomatic moderate-severe obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 2009; 179: 501-508.
26. Eastwood PR, Malhotra A, Palmer LJ, et al. Obstructive Sleep Apnoea: from pathogenesis to treatment: current controversies and future directions (Think Tank Review). Respirology 2010; 15: 587-595.